Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges

Triple negative breast cancer (TNBC) is an aggressive breast cancer with historically poor outcomes, primarily due to the lack of effective targeted therapies. The tumor molecular heterogeneity of TNBC has been well recognized, yet molecular subtype driven therapy remains lacking. While neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin Sun, Yost, Susan E., Yuan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352772/
https://www.ncbi.nlm.nih.gov/pubmed/32486021
http://dx.doi.org/10.3390/cancers12061404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352772/
https://www.ncbi.nlm.nih.gov/pubmed/32486021
http://dx.doi.org/10.3390/cancers12061404

Ejemplares similares